Liver cancer becomes more preventable and treatable
This article was originally published in Scrip
Executive Summary
New drugs to treat viral hepatitis infection, coupled with renewed interest from companies in developing therapies to treat liver cancer following Nexavar's approval, have improved prospects for both preventing and treating the long-neglected but increasingly prevalent cancer, writes Malini Guha